Hims & Hers Health, Inc. (NYSE:HIMS) launched the Service Appreciation Initiative, offering compounded GLP-1 weight loss medications to some personnel for as low as $99 per month. The initiative covers eligible U.

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain professions for $99 a month. The company said the pricing would be available to eligible U.

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare, today announced access to the most common compounded GLP-1 subscriptions for as low as $99 a month for eligible U.

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for under $100.